临床试验/ACTRN12619001493134

ACTRN12619001493134尚未招募3 期

A randomised, cross-over clinical trial to evaluate the equivalence of a reformulated Co-phenylcaine spray incorporating taste masking and flavouring agents as compared to the currently marketed Co-phenylcaine Forte spray in providing anaesthesia for nasendoscopy procedures

Curtin University0 个研究点目标入组 22 人开始时间: 2019年10月29日最近更新: 2019年11月4日

试验速览

阶段: 3 期
状态: 尚未招募
发起方: Curtin University
入组人数: 22

研究概览研究设计入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional
分配方式: Randomised controlled trial
主要目的: Treatment
盲法: Blinded (masking used)

入排标准

年龄范围: 18 Years 至 o limit（—）
性别: All

入选标准

•Patients attending an Ear nose and throat (ENT) practice for nasendoscopy examination and minor surgical procedures.

排除标准

•significant oral disease or injury, any known impairment of taste function and any history of cardiac, liver or kidney conditions.

研究者

发起方

Curtin University

相似试验

Clinical study to evaluate the efficacy and tolerability of the Meneguetti brush for self-collection of anal specimens to screen for anal cancer and sexually transmitted infectionsSexually Transmitted Diseases (STD)C04.588.274.476.411.307.790Anal Cancer

RBR-6nxst93Instituto Nacional de Infectologia Evandro Chagas - Fiocruz

Clinical trial for evaluating validity of various acupuncture device types

KCT0001347Kyung Hee University Oriental Medical Center76

Myopia Progression and Orthokeratology Lens WearProgressing mild late-onset myopiaEye - Diseases / disorders of the eye

ACTRN12606000054516Dr Helen Owens, Senior Lecturer, Department of Optometry, University of Auckland50

A randomized, controlled clinical trial to evaluate the efficacy of the digital Cognitive Behavioral Therapy somnio junior to reduce symptoms of insomnia in adolescens suffering from insomnia after three months of applicatioInsomnia (F51.0/G47.0) in adolescents (14-17 years)F51.0G47.0Nonorganic insomniaDisorders of initiating and maintaining sleep [insomnias]

DRKS00033527mementor DE GmbH60

进行中（未招募）

Ambulatory Oxygen in Fibrotic Lung DiseaseFibrotic Lung Diseases (FLDs) are chronic and progressive conditions resulting in substantial morbidity and mortality. The cardinal symptom of all fibrotic Interstitial Lung Diseases (ILDs) is shortness of breath. Although initially present only on strenuous activities, this unfortunately progresses until even routine activities of daily living become severely limited. This has a devastating impact on Quality of Life (QOL).MedDRA version: 16.1Level: PTClassification code 10022611Term: Interstitial lung diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders

EUCTR2013-004355-20-GBRoyal Brompton and Harefield NHS Foundation Trust